• Optiscan unveils InForm™, a groundbreaking microscopic medical imaging device designed for pathology workflows
• InForm™ expands Optiscan's product portfolio into the pathology market, a pivotal milestone in the company's strategic objectives
• InForm™ can be used in various pathology settings, including laboratory medicine, pathology practice, point-of-care, and digital pathology

Optiscan Imaging Ltd (ASX:OIL) is pleased to announce the reveal of InForm™, a groundbreaking microscopic medical imaging device specifically designed to transform pathology by delivering real-time digital insights across the full pathology workflow at point of contact with a tissue sample. The device has been designed and manufactured in Melbourne by Optiscan in partnership with industrial design firm Design + Industry. InForm™ extends Optiscan's product range and marks a pivotal advancement in the Company's strategic portfolio expansion. Utilizing Optiscan's proprietary technology, this device is crafted specifically for pathologists and pathology technicians to obtain immediate insights to improve diagnostics across laboratory medicine, pathology practice and point-of-care practices to enhance real-time decision-making and redefine diagnostic workflows. This represents a new frontier in clinical pathology by propelling real-time digital insights to the forefront of diagnostics. Through InForm™, Optiscan is reshaping traditional practices, enabling faster, more accurate decision-making, and supporting a seamless transition to digital pathology. This foray into a new clinical sphere represents a significant step forward for the Company, providing pathologists and clinicians with innovative tools to enhance patient care, reduce diagnostic delays, and address the growing demand for precision medicine.

Optiscan now looks forward to updating the market on further InForm™ device-specific developments over coming months, including its planned integration with Optiscan's cloud-based telepathology streaming platform.